Targeted Radiopharmaceuticals Summit
June 11 - 13, 2019 - München DEHanson Wade
info@hansonwade.com
Phone:+44 (0)20 3141 8700
Welcome to Targeted Radiopharmaceuticals (TRP) Summit, the industry-led forum designed to accelerate the development of next-generation radiopharmaceuticals. The faculty of expert speakers will lead us through a comprehensive discussion of the challenges and opportunities currently facing this space as it undergoes an exciting resurgence. We have been working with companies including: Endocyte, MTR, Actinium Pharmaceuticals, Tagworks, Bayer and Roche, to assemble this agenda. The key focus of which will be exploring how to advance the therapeutic potential of radiation. The important role of diagnostic imaging is also key to providing a truly well-rounded conference in this field. As such, fully appreciating the potential that combinations of theranostics and diagnostics offer will be integral throughout. The main areas of focus include: - Identifying and Assessing the Therapeutic Potential of Novel Targets - Updates on the New Regulatory Hurdles in the US and EU - Optimising Chemical Modification Methods and Combination Rationale - Radioimmunotherapy and Beyond Early booking and group discounts apply, start-up and academic rates are available - see the website for details.